Seven-valent pneumococcal conjugate vaccine in pediatric solid organ transplant recipients: a prospective study of safety and immunogenicity.

Abstract

OBJECTIVES To determine the safety and immunogenicity of the conjugate pneumococcal vaccine (PCV7) in pediatric solid organ transplant recipients. PATIENTS AND METHODS Pediatric solid organ transplant recipients were prospectively enrolled at > or =4 months following transplantation. Eligible pneumococcal vaccine-naive subjects received 3 doses of PCV7 at… (More)
DOI: 10.1097/INF.0b013e31819d97be

2 Figures and Tables

Topics

  • Presentations referencing similar topics